Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as ...
Dr. Collins brings extensive drug development and clinical expertise in epilepsy --NEW YORK and VANCOUVER, British Columbia, Jan. 07, 2025 ...